Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neogen (NEOG) Shares Outstanding (Weighted Average): 2010-2025

Historic Shares Outstanding (Weighted Average) for Neogen (NEOG) over the last 15 years, with Aug 2025 value amounting to $217.2 million.

  • Neogen's Shares Outstanding (Weighted Average) rose 0.24% to $217.2 million in Q3 2025 from the same period last year, while for Nov 2022 it was $107.8 million, marking a year-over-year increase of 0.32%. This contributed to the annual value of $217.0 million for FY2025, which is 0.20% up from last year.
  • Latest data reveals that Neogen reported Shares Outstanding (Weighted Average) of $217.2 million as of Q3 2025, which was up 0.08% from $217.0 million recorded in Q2 2025.
  • Over the past 5 years, Neogen's Shares Outstanding (Weighted Average) peaked at $217.2 million during Q3 2025, and registered a low of $106.5 million during Q1 2021.
  • Moreover, its 3-year median value for Shares Outstanding (Weighted Average) was $216.6 million (2024), whereas its average is $216.6 million.
  • Data for Neogen's Shares Outstanding (Weighted Average) shows a peak YoY soared of 100.59% (in 2023) over the last 5 years.
  • Quarterly analysis of 5 years shows Neogen's Shares Outstanding (Weighted Average) stood at $107.5 million in 2021, then rose by 0.32% to $107.8 million in 2022, then soared by 100.59% to $216.3 million in 2023, then climbed by 0.18% to $216.7 million in 2024, then grew by 0.24% to $217.2 million in 2025.
  • Its last three reported values are $217.2 million in Q3 2025, $217.0 million for Q2 2025, and $216.9 million during Q1 2025.